background: Although previous reports suggest an antigen-presenting function for decidual stromal cells (DSCs), the relevance of cellto-cell communication between DSCs and T cells at the human feto-maternal interface has not been fully elucidated. Therefore, we investigated the presence and function of human DSC-expressed B7-H1 and B7-DC co-stimulatory ligands. B7-H1 and B7-DC on peripheral antigen-presenting cells (APC) typically inhibit T cell activation after binding to their corresponding receptor, programmed death-1 (PD-1).
Introduction
The anatomical structure of the feto-maternal unit places the uterine decidua, a pregnancy-specific endometrial tissue, as a first-line protector against invasion of external infectious micro-organisms. The recognition of pathogen by immunocompetent decidual cells and the resulting immune activation is indispensable in the prevention of adverse outcomes such as preterm labor (Lockwood, 1994; Dudley, 1997) . Conversely, decidual cells also need to possess the capacity for immunologic suppression to allow for tolerance of the fetal semiallograft and to avoid excessive reaction to the typically small but frequent exposure to microbial pathogens (Szekeres-Bartho, 2002; Saito pregnancy . To date, a detailed description of the communication between DSCs and maternal decidual lymphocytes remains incomplete.
In the periphery, antigen recognition by CD4 þ T cells is initiated by the binding of the T cell receptor (TCR) to antigen associated with major histocompatibility complex (MHC) class II molecules expressed on the surface of antigen-presenting cells (APCs). This primary signaling is modulated by a second pathway of co-stimulatory signaling to determine the level of T cell activation (Mueller et al., 1989) . Positive or negative regulation of CD4 þ T cell function, including cytokine production and clonal expansion, depends on the types of co-stimulatory ligands expressed on APCs. The B7 superfamily is a major group of co-stimulatory ligand molecules. B7.1 (CD80) and B7.2 (CD86) were the earliest of these molecules to be described (Freeman et al., 1991 (Freeman et al., , 1993 and interactions with their receptors, CD28 and cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) are the best characterized of the co-stimulatory pathways (Schwartz, 1992) . Recently, a number of new B7 family members have been identified, including B7-H1 (programmed death ligand 1 (PD-L1) or CD274), B7-DC (PD-L2 or CD273) and B7-H2 (ICOSL or B7-RP1) (Dong et al., 1999; Wang et al., 2000; Latchman et al., 2001; Tseng et al., 2001) . Programmed death-1 (PD-1) is expressed on activated T and B cells and acts as a receptor for both of B7-H1 and B7-DC (Ishida et al., 1992; Agata et al., 1996) . The engagement of PD-1 with its ligands typically generates an inhibitory signal, leading to the suppression of T cell activation (Freeman et al., 2000; Latchman et al., 2001 ). B7-H1 and B7-DC differ in their expression patterns. B7-H1 is expressed in a variety of cell types, including T and B cells, dendritic cells, macrophages and a diverse array of parenchymal cells (Ishida et al., 2002; Yamazaki et al., 2002) . In contrast, the expression of B7-DC is tightly restricted to dendritic cells and macrophages (Yamazaki et al., 2002) . Increasing evidence suggests a critical role for PD-1:PD ligand interactions in autoimmunity and immune tolerance. PD-1-deficient mice develop a lupus-like autoimmune disease (Nishimura et al., 1999) and autoimmune dilated cardiomyopathy (Nishimura et al., 2001 ). Aberrant T cell response to PD-1 ligands is suggested in autoimmune hepatitis (Mataki et al., 2007) , chronic nephritis (Chen et al., 2006; Das et al., 2006; Menke et al., 2007) , asthma (Matsumoto et al., 2004) and inflammatory bowel disease (Kanai et al., 2003) . Co-stimulatory signaling that is delivered from dendritic cells via B7-H1 but not B7-DC is required for conversion of naïve CD4 þ T cells into Foxp3 þ regulatory T cells (Wang et al., 2008) . More intriguingly, blockade of B7-H1 signaling during murine pregnancy increases the rejection rates of allogenic, but not syngeneic concepti (Guleria et al., 2005) . Although the expression of B7 family molecules (including B7-H1 and B7-DC) has been reported in the human placenta (Petroff et al., 2002 (Petroff et al., , 2005 , the role of these co-stimulatory ligands in human pregnancy has not been elucidated. We sought to clarify the involvement of the PD-1:PD ligand pathway in immune regulation at the feto-maternal interface.
Prior investigations have reported that particular subsets of stromal cells have the capacity to function as non-professional APCs with constitutive or stimulation-induced expression of MHC class II molecules. For example, some neoplastic cells and tumor-associated stromal cells cross-present tumor antigens, leading to the induction of tumorspecific T cell cytotoxicity (Zhang et al., 2007) . Colonic myofibroblasts expressing MHC class II along with B7.1 and B7.2 stimulate allogeneic CD4 þ T cell proliferation (Saada et al., 2006) . In the uterus, DSCs have been shown to express MHC class II molecules and to display an ability to stimulate allogenic T cells in vitro (Olivares et al., 1997) . However, the role for co-stimulation in DSC/maternal T cells crosstalk has not been well described.
In the present study, we explored the expression and functional role of B7 family molecules to clarify whether DSCs can act as nonprofessional APCs. After confirming the constitutive expression of B7-H1 and B7-DC on DSCs, we examined how those DSC-expressed PD-1 ligands modulate cytokine production from CD4 þ T cells.
Materials and Methods

Monoclonal antibodies
Purified mouse anti-human CD3 monoclonal antibodies (mAb) (OKT3), FITC-conjugated mouse anti-human CD14 (61D3), CD45 (HI30), CD9 (eBioSN4), CD31 (WM-59) mAbs, purified or PE-conjugated mouse antihuman B7-H1 (MIH1), B7-DC (MIH18), B7-H2 (MIH12) B7-1 (2D10.4), B7-2 (IT2.2), CD11c (3.9) mAbs and allophycocyanin-conjugated mouse anti-human HLA-DR (LN3) mAb were obtained from eBioscience (San Diego, CA). Functional grade purified mouse anti-human HLA-DR (L243) was purchased from Biolegend (San Diego, CA). Anti-human vimentin mAbs (V9, Sigma Aldrich) and anti-cytokeratin mAbs (LP5K, Millipore, Billerica, MA) were used to confirm the identity of DSCs. Mouse IgG isotype controls were purchased from eBioscience.
Sample collection
Human term placentas (n ¼ 16) were collected from Cesarean section cases performed at 37 -39 weeks of gestation solely for the indication of prior Cesarean section. Cases lacking maternal or fetal complications were selected for tissue sampling. Informed consent was obtained and the use of human tissues was conducted under the IRB approval at the University of Missouri.
Isolation and culture of DSCs
A thin layer of decidual tissues was carefully scraped from the maternal surface of placenta and fetal membranes. After washing in phosphatebuffered saline (PBS), the tissue was minced and enzymatically digested in Hank's balanced salt solution (Invitrogen, Carlsbad, CA) supplemented with 1 mg/ml type I collagenase, 2 mg/ml type I-S hyaluronidase and 300 U/ml DNAse 1 (Sigma Aldrich) for 60 min at 378C. The resulting cell suspension was filtered through a 70-mm cell strainer (BD biosciences, San Jose, CA) and centrifuged at 300 g for 10 min. Cell pellets were re-suspended in PBS, layered on Histopaque 1077 (Sigma Aldrich) and centrifuged at 400 g for 20 min without brake. Cells floating at the resulting interface were collected and washed twice in PBS. The cells were then suspended in RPMI-1640 containing 10% fetal bovine serum (FBS) and incubated in a culture flask for 3 h at 378C. Supernatants containing decidual lymphocytes and debris were removed and the attached cells were recollected using 0.05% trypsin-EDTA (Invitrogen). Contaminating macrophages were removed using CD14 immunomagnetic beads (MACS, Miltenyi Biotec, Auburn, CA) according to the manufacturer's instructions. The remaining DSCs were seeded into flasks and cultured at 378C under 5% carbon dioxide and 95% air. DSCs proliferated to confluency in 5 -6 days and were then used in the following assays. In all experiments, RPMI-1640 with 10% FBS and 50 mg/ml gentamicin (Invitrogen) was used as the DSC culture medium.
Functional PD-1 ligand expression on DSCs Identity of the DSCs was confirmed using immunostaining and flow cytometry. DSCs are negative for cytokeratin (a marker for trophoblasts and epithelial cells), CD14 (a marker for macrophages), CD45 (a marker for hematopoietic cells), CD11c (a marker for macrophages and dendritic cells), B7.2 (a marker for macrophages and dendritic cells) and CD31 (a marker for endothelial cells) and are positive for vimentin and CD9 in flow cytometric analyses. The average purity of the DSCs used in this study was greater than 99.9%.
Immunocytochemical staining
Following negative selection using CD14 immunomagnetic beads, DSCs were cultured on chamber slides (Electron Microscopy Sciences, Hatfield, PA) for 5 days. In some experiments, freshly isolated, crude DSCs were cultured under the same conditions without immunomagnetic purification. The cells were fixed in acetone-methanol (1:1) for 10 min at 48C. Immunocytocheminal staining was carried out using a VECTASTAIN ABC kit (Vector Laboratories, Burlingame, CA) following the manufacture's instructions. Endogenous peroxidase activity was quenched using 0.3% H 2 O 2 /PBS and non-specific staining was blocked using 1.5% normal horse serum/PBS. The slides were incubated with primary antibodies diluted to the appropriate concentrations for 1 h at room temperature. Normal mouse IgG (Santa Cruz Biotechnology, Santa Cruz, CA) was used as a negative control. After washing three times with PBS, the slides were incubated with biotinylated anti-mouse IgG horse IgG for 30 min at room temperature. The slides were then washed three additional times and exposed to avidin/peroxidase solutions. Specific staining was visualized using 3,3-diaminobenzidine according to standard protocols. Slides were then counterstained using Mayer's hematoxylin (Sigma).
Flow cytometric analysis
To determine the effects of cytokines on the surface expression of B7 family molecules, DSCs were cultured in 6-well plates in the presence or absence of 10 ng/ml IFN-g,10 ng/ml TNF-a or a combination of IFN-g and TNF-a for 5 days. The cells were harvested via brief trypsinization and washed twice with FACS buffer. Prior studies (data not shown) had confirmed that antibody reactivity to the molecules under investigation here was not affected by trypsinization. Cells were immunostained using FITC, PE or allophycocyanin-conjugated mAbs for 30 min at 48C. Fluorescence-conjugated isotype-matched mouse IgG was used for negative controls. After washing three times, the cells were resuspended in 500 ml of FACS buffer and assessed using a FACSCaliber instrument (Becton Dickinson, Mountain View, CA).
Real-time PCR
DSCs were cultured in the presence or absence of various concentrations of IFN-g, TNF-a or a combination of IFN-g and TNF-a (1, 10 and 100 ng/ml) for 72 h. Total RNA was extracted from the cells using an RNeasy Mini kit (Qiagen, Valencia, CA) following the manufacturer's instructions. Optical density (OD) 260/280 nm ratios were measured using a NanoDrop 1000 spectrophotometer (Thermo Scientific, Wilmington, DE) to determine the RNA quantity and purity of RNA preparations. Fixed amounts of total RNA (0.5 mg) were reverse transcribed into cDNA using random primers and Superscript III (Invitrogen) followed by RNaseH digestion.
Relative quantification of gene expression was performed using the ABI Prism 7500 system (Applied Biosystems, Foster City, CA). Complementary DNA (12.5 ng) was added as a template in a total volume of 20 ml containing the PCR reaction mixture (Platinum SYBR Green qPCR SuperMix-UDG, Invitrogen). Expression of 18 s ribosomal RNA was determined to allow normalization in each sample. The primer sequences used were: (i) B7-H1 (NM_014143) sense 5 0 -TCA ATG CCC CAT ACA ACA AA-3 0 , antisense 5 0 -GCT TGT CCA GAT GAC TTC G-3 0 ; (ii) B7-DC (NM_025239) sense 5 0 -GTA CAT AAT AGA GCA TGG CAG CA-3 0 , antisense 5 0 -CCA CCT TTT GCA AAC TGG CTG T-3 0 and (iii) 18s rRNA (NR_003286) sense 5 0 -TGA GAA ACG GCT ACC ACA TC-3 0 , antisense 5 0 -TTA CAG GGC CTC GAA AGA GT-3 0 . The PCR cycle protocol consisted of: 508C for 2 min (UDG incubation), 958C for 2 min (denaturation) and 40 cycles of: 958C for 15 s, 608C for 30 s, followed by melting curve analysis. All PCR reactions were performed in triplicate. The PCR product inserted into the pCRII-TOPO plasmid vector was subcloned using a TOPO TA cloning kit (Invitrogen). Its nucleotide sequence was confirmed using standard sequence analysis.
DSC/CD4
1 T cell co-culture and antibody blockade
Peripheral blood mononuclear cells (PBMCs) were isolated from peripheral blood of healthy donors using gradient centrifugation across Histopaque 1077. Human CD4 þ T cells were isolated by positive selection using anti-CD4 immunomagnatic beads (MACS, Miltenyi Biotec) following the manufacturer's instructions.
DSCs were pre-incubated in the presence or absence of 10 ng/ml IFN-g for 5 days. DSCs were treated with 25 mg/ml mitomycin C (Sigma Aldrich) for 20 min and were reseeded onto 96-well plates at a concentration of 2 Â 10 4 cells per well. The following blocking antibodies were added into the culture: (i) anti-B7-H1 mAb (10 mg/ml, MIH1), (ii) anti-B7-DC mAb (10 mg/ml, MIH18) or (iii) both anti-B7-H1 and anti-B7-DC mAb (10 mg/ml each). In some experiments, anti-HLA-DR (2 mg/ml, L243) was added to examine the relevance of TCR/class II MHC interactions. Normal mouse IgG (10 mg/ml) was used in control wells. After 3 h of incubation, unbound antibodies were removed by washing twice with the culture medium. Freshly isolated allogenic CD4 þ T cells (2 Â 10 4 per well) were added in combination with anti-CD3 mAbs (200 ng/ml, OKT3). Co-cultures were incubated for 24 h and culture media was collected and stored at 2808C for batched cytokine measurement.
Cytokine measurement
The concentrations of cytokines (IFN-g, TNF-a, IL-2 and IL-10) were determined using ELISA (ELISA MAX set, Biolegend) following the manufacturer's instructions. When measured cytokine concentrations exceeded the assays' limits of detection, samples were diluted with 1% BSA/ PBS. The minimal assay levels of detection were 8 pg/ml for IFN-g and 4 pg/ml for TNF-a, IL-2 and IL-10. Measured concentrations below the detectable dose were considered zero.
Statistical analysis
One-way factorial analysis of variance followed by Bonferroni's post hoc testing was used to assess the data from real-time PCR and the co-culture studies that examined the blocking effects of B7-H1 and B7-DC. The Mann-Whitney's U-test was used to examine the co-culture data from HLA-DR blocking assays. A value of P , 0.05 was considered significant.
Results
Purification of cultured DSCs
Macrophages are known to express B7 family molecules. They represent a major cellular component within the human decidua, comprising 5-10% of the stromal compartment (Repnik et al., 2008) . In our preliminary work, flow cytometric analysis indicated that crude DSCs, isolated only by attachment on culture plates, contained a moderate percentage of CD14þ decidual macrophages (5 -13%) (Fig. 1A) . We therefore added a purification step to our protocols, removing CD14þ cells using immunomagnetic beads from attached decidual cells (Fig. 1C) . Using this purification step, CD14þ cells consistently comprised less than 0.05% of isolated DSCs (Fig. 1B) . Decidual macrophages and dendritic cells are known to express B7-2 and CD11c (Heikkinen et al., 2003; Miyazaki et al., 2003) . To examine the extent of contamination with decidual macrophages and dendritic cells in our purified DSCs, we also conducted immunocytochemical staining of these cells for B7-2 and CD11c after 5 days in culture. While a significant number of cells positive for B7-2 and CD11c were observed in cultures of crude DSCs without immunomagnetic selection, staining for B7-2 and CD11c was absent in purified DSCs (Fig. 2) . The DSCs prepared for our investigations were optimally purified to minimize the effects of confounding alternative APCs, including decidual macrophages and dendritic cells.
Expression of B7 family molecules on DSCs
To examine whether B7 family molecules were expressed on DSCs, we conducted flow cytometric analyses. Freshly isolated DSCs expressed B7-H1 and B7-DC but not B7-1, B7-2 and B7-H2 by Functional PD-1 ligand expression on DSCs flow cytometry (Fig. 3) . Consistent low-level expression of HLA-DR was also documented on unstimulated DSCs (Fig. 3) . The cell surface co-expression of class II MHC and B7 family molecules suggested a potential role for DSCs as non-professional APCs.
The effect of IFN-g and TNF-a on the expression of B7-H1, B7-DC and HLA-DR on DSCs
Surface expression of immunoregulatory molecules, including co-stimulatory molecules and MHC, is controlled by inflammatory cytokines (Rosa et al., 1983; Creery et al., 1996) . Key inflammatory cytokines from activated T cells are known to alter the expression of B7 family molecules in cell type-specific patterns (Chang et al., 1995; Mazanet and Hughes, 2002; de Haij et al., 2005; Usui et al., 2008) . Among the inflammatory cytokines, IFN-g and TNF-a have received particular attention. We therefore examined the effects of IFN-g and TNF-a on the transcription of PD-1 ligands and HLA-DR by DSCs. DSCs were cultured for 72 h in the presence of IFN-g, TNF-a or combination IFN-g and TNF-a. B7-H1 and B7-DC mRNA levels were assessed using real-time PCR. The addition of either IFN-g or TNF-a significantly increased B7-H1 and B7-DC mRNA levels in DSCs in a dose-dependent manner (Fig. 4) . IFN-g and TNF-a had additive effects on B7-H1 and B7-DC mRNA levels (Fig. 4) .
To determine the expression levels of co-stimulatory proteins, DSCs were again cultured in the presence of IFN-g and/or TNF-a for 5 days and analyzed using flow cytometry. DSC surface expression of B7-H1 and B7-DC were increased in the presence of IFN-g alone and TNF-a alone (Fig. 5A) . Consistent with the findings at the mRNA level, combined stimulation with IFN-g and TNF-a increased B7-H1 and B7-DC expression more than exposure to either IFN-g alone or TNF-a alone (Fig. 5A ).
Although consistent low-level cell surface expression of HLA-DR was detected on freshly isolated DSCs (Fig. 3) , it was lost after several days in culture in the absence of cytokine exposure. As expected, however, IFN-g exposure markedly increased the HLA-DR expression on DSCs (Fig. 5A ). TNF-a exposure had no demonstrable effect on HLA-DR expression and no additive effects were observed when DSCs were exposed to a combination of TNF-a and IFN-g (compared with IFN-g alone). B7-1, B7-2 and B7-H2 were not expressed on DSCs, even after exposure to IFN-g and/or TNF-a (Fig. 5B) .
HLA-DR on DSCs enhances cytokine production from CD4
1 T cells in allogenic co-cultures (Fig. 6) DSC HLA-DR and co-stimulatory molecule expression results led us to hypothesize that DSCs can regulate cytokine production from CD4 þ T cells through molecular interactions mediated by class II MHC and the PD-1 ligands, B7-H1 and B7-DC. To test this hypothesis, we conducted co-culture experiments using human DSCs and allogenic T cells. Peripheral CD4 þ T cells stimulated with an anti-CD3 mAb were co-cultured with IFN-g-pretreated (10 ng/ml for 5 days) or naive DSCs to investigate whether IFN-g-induced HLA-DR expression on DSCs affected cytokine production by activated CD4 þ T cells. DSCs and allogenic CD4 þ T cells were co-cultured for 24 h and supernatants were collected for IFN-g, Figure 3 The expression of B7 family molecules and HLA-DR on freshly isolated human DSCs. DSCs were freshly isolated from human term decidual samples and immuno-stained with mAbs against HLA-DR or B7 family molecules (B7-H1, B7-DC, B7.1, B7.2 and B7-H2). In each histogram, the shaded regions represent isotype controls and unshaded regions represent specific immuno-staining. The data shown are representative of five experiments using individual decidual samples.
TNF-a, IL-2 and IL-10 ELISAs. None of these cytokines were detected in supernatants from DSCs cultured alone. All cytokines studied underwent similar alteration patterns. When compared with CD4 þ T cells cultured alone, cytokine production in T cell/DSC co-cultures was significantly enhanced by HLA-DR blockade (Fig. 6 ). Increases were higher when allogenic CD4 þ T cells were co-cultured with IFN-g-pretreated versus non-pretreated DSCs. In the presence of antibody blockade of the interaction between HLA-DR and the TCR, increases in cytokine production were nearly abrogated in co-cultures using non-pretreated and IFN-g-pretreated DSCs. We therefore concluded that enhanced cytokine production observed in the co-culture with IFN-g-pretreated DSCs was the result of the up-regulation in surface expression of HLA-DR following IFN-g stimulation. These findings demonstrate that the molecular interaction between TCRs on CD4 þ T cells and MHC class II molecules on DSCs are an essential trigger for cytokine production from CD4 þ T cells.
B7-H1 and B7-DC on DSCs suppress cytokine production from CD4 1 T cells (Fig. 7) It has been proposed that B7-H1 and B7-DC deliver inhibitory co-stimulatory signals to peripheral T cells (Freeman et al., 2000) .
We therefore clarified whether B7-H1 and B7-DC expressed on human DSCs are involved in the regulation of cytokine production from CD4 þ T cells in allogenic co-cultures. Again DSCs were either pretreated with IFN-g (10 ng/ml for 5 days) or were untreated prior to introduction into co-culture. Both types of DSCs were also pre-exposed to B7-H1 and B7-DC blocking mAbs prior to the addition of CD4 þ T cells into co-culture. Surplus unbound blocking antibodies were removed immediately after blockade to avoid direct interaction with surface ligands on CD4 þ T cells. Co-culture supernatants were collected at 24 h and cytokine secretion (IFN-g, TNF-a, IL-2 and IL-10) measured using ELISA. IFN-g, TNF-a and IL-2 were significantly increased by blocking B7-H1 interactions. Similar, albeit lesser, results were seen upon B7-DC blockade. When compared with blockade of a single co-stimulatory pathway, the dual blockade of B7-H1 and B7-DC enhanced both IFN-g and TNF-a production, but did not alter the secretion of IL-2 and IL-10. The effects of antibody blockade on IL-10 production was consistently less than the effects on IFN-g, TNF-a and IL-2 secretion, reaching statistical significance only when controls were compared with dual blockade. The effects of co-stimulatory pathway blockade were significantly lessened when non-pretreated DSCs were used in co-culture rather than IFN-g-pretreated DSCs. These observations are thought to be attributable to those differences in the intensities of PD ligand expression on naïve and IFN-g-pretreated DSCs we previously demonstrated in our expression analyses. It should be noted that cytokine secretion from naïve DSC co-cultures under dual PD ligand blockade was lower than that in IFN-g-pretreated DSC co-cultures without blockade. Taken together with our data on HLA-DR-mediated interactions, CD4
þ T cell cytokine production appears to be primarily determined by the HLA-DR expression level on DSCs. The inhibitory modulation caused by PD-1 ligand pathways seems to refine signaling generated through TCR-MHC class II interactions.
Discussion
Our present investigations have demonstrated that the PD-1 ligands, B7-H1 and B7-DC but not B7.1, B7.2 and B7-H2, are expressed on human DSCs. Transcription and cell surface expression of B7-H1 and B7-DC on DSCs is enhanced upon exposure to IFN-g and TNF-a, whereas HLA-DR expression on DSCs is increased by IFN-g but not by TNF-a. Allogenic co-culture studies revealed that those interactions between DSC and CD4 þ T cells mediated by HLA-DR lead to activation of CD4 þ T cell cytokine production.
Additionally, in the same co-culture setting, cytokine production by CD4 þ T cells was enhanced by blockade of PD-1 ligands on DSCs,
suggesting that the function of B7-H1 and B7-DC on DSCs is to inhibit the downstream effects of HLA-DR interactions.
To obtain highly purified DSC cultures, we removed CD14 þ decidual macrophages from attached decidual cell populations using immunomagnetic selection. Purified DSCs expanded in culture for 5-6 days exhibited homogenous morphology. Immunostaining of purified DSCs for B7-2 and CD11c after 5 days in culture indicated that our DSCs were free of contaminating decidual macrophages and dendritic cells, minimizing the potential for confounding alternative APCs affecting T-cell responses in our co-culture assays.
Figure 4 IFN-g and TNF-a up-regulate the B7-H1 and B7-DC mRNA expression on DSCs. DSCs were cultured in the presence or absence of a variety of concentrations of IFN-g and/or TNF-a for 72 h. B7-H1 and B7-DC mRNA levels were evaluated using realtime PCR. Messenger RNA were normalized using 18 s rRNA and the values shown are relative to those in control cultures (IFN-g 0 ng/ml, TNF-a 0 ng/ml). Data are based on six independent experiments using DSCs derived from individual decidual samples. *P , 0.05, **P , 0.01. Error bars ¼ S.E.
Functional PD-1 ligand expression on DSCs Figure 5 The effects of IFN-g and TNF-a on cell surface expression of HLA-DR and B7 family members. DSCs were cultured in the presence or absence of 10 ng/ml IFN-g and/or 10 ng/ml TNF-a for 96 h. Cell surface expression of B7 family molecules and HLA-DR was analyzed using flow cytometry. While B7-H1 expression has been reported on a wide range of cells, including neoplastic and parenchymal cells residing in inflammatory tissues, B7-DC expression on non-hematopoietic cells under non-pathologic conditions is relatively rare (Ishida et al., 2002; Yamazaki et al., 2002; Liang et al., 2003) . To date, co-expression of B7-H1 and B7-DC has only been observed in cells that present antigen, including dendritic cells, macrophages (Yamazaki et al., 2002) , endothelial cells (Rodig et al., 2003) and airway epithelial cells (Tsuda et al., 2005) . The expression analysis in this study showed that DSCs express both B7-H1 and B7-DC. The uncommon B7 family expression profile of DSCs therefore suggests a capacity to act as non-professional APCs. Freshly isolated DSCs from mature placentas also express low levels of HLA-DR, again supporting a role in antigen presentation, particularly to CD4 þ T cells. Others have reported that DSCs from placentas early in gestation express HLA-DR but late gestation placentas lack expression (Oliver et al., 1999) . Our own investigations reveal that surface expression is lost over time in culture unless IFN-g is present. These somewhat Figure 6 HLA-DR expression on DSCs enhances cytokine production from CD4 þ T cells. DSCs were pretreated with or without IFN-g (10 ng/ml) for 5 days. HLA-DR on DSCs was blocked using a specific mAb and then allogenic CD4 þ T cells, together with anti-CD3 mAb (200 ng/ml), were added to create co-culture conditions. Non-specific mouse IgG was substituted for the anti-HLA-DR mAb in control cultures. Twenty-four hours into co-culture, the concentrations of IFN-g, TNF-a, IL-2 and IL-10 were measured in the culture media using standard ELISAs. DSC (2) discrepant results may reflect differences in the timing of surface expression assessment after DSC isolation.
DSC surface expression of B7-H1 and B7-DC is strongly enhanced by IFN-g and moderately increased by TNF-a. The combination of IFN-g and TNF-a exerts a synergistic effect. The human B7-H1 promoter contains IFN regulatory factor-1 binding sites between 202 and 320 bp upstream of the translational start site (Seung-Jin et al., 2006) . Although transcriptional regulation of B7-DC has not been demonstrated, B7-DC up-regulation in response to IFN-g has been observed in dendritic cells and macrophages (Yamazaki et al., 2002) . The effects of TNF-a on B7-H1 and B7-DC varies by the cell type studied. As in our investigations, the effects of TNFa in combination with IFN-g on co-stimulatory ligand expression in human umbilical endothelial cells are additive (Mazanet and Hughes, 2002; Rodig et al., 2003) .
Most recent studies have suggested that B7-H1/B7-DC play an inhibitory role in co-stimulatory signaling. Ligation to PD-1 delivers downstream inhibitory signals by suppressing phosphatidylinositol 3-kinase/AKT activation. This activity is mediated by an immunoreceptor tyrosine-based motif located in the cytoplasmic tail of PD-1 (Parry et al., 2005) . Although some initial investigations suggested activating functions for PD-1 ligands (Dong et al., 1999; Tseng et al., 2001) , the discrepancy between this and other reports is now thought to be attributable to an, as yet unidentified, alternative receptor.
Our co-culture results demonstrate that signaling mediated by DSC-expressed PD-1 ligands inhibits allogenic CD4 þ T cell cytokine production, which supports an inhibitory co-stimulatory function for B7-H1 and B7-DC. To assure that these effects were not mediated by direct interactions of free PD-1 ligand blocking antibody with PD-1 ligands on T cells in co-culture, DSCs were extensively washed prior their exposure to allogenic T cells. B7-H1 and B7-DC on DSCs appear to have similar and redundant effects on CD4 þ T cell cytokine production as dual blockade of B7-H1 and B7-DC increased cytokine secretion in an additive fashion. Similar functional Figure 7 B7-H1 and B7-DC on DSCs suppress inflammatory cytokine production from CD4 þ T cells. DSCs were pretreated with or without IFN-g (10 ng/ml) for 5 days. B7H1 and B7-DC on DSCs were blocked using a specific mAbs and then allogenic CD4 þ T cells together with anti-CD3 mAb (200 ng/ml) were added to create co-culture conditions. Non-specific mouse IgG substituted for the anti-HLA-DR mAb in control cultures. Twentyfour hours into co-culture, the concentrations of IFN-g, TNF-a, IL-2 and IL-10 were measured in the culture media using standard ELISAs. IFN-g Pret.(2): co-culture with naïve DSCs. IFN-g Pret.(þ): co-culture with IFN-g pretreated DSCs. aB7-H1: blockade of B7-H1. aB7-DC: blockade of B7-DC. Dual: blockade of both B7-H1 and B7-DC. The data shown represent seven experiments using DSCs derived from individual decidual samples. n.s.: no significance, *P , 0.05, **P , 0.01. Error bars ¼ S.E. redundancy between B7-H1 and B7-DC has been reported in dendritic (Brown et al., 2003) and endothelial cells (Rodig et al., 2003) .
The physiologic role of IFN-g in human pregnancy is complex. Both beneficial and harmful effects have been described. IFN-g produced from uterine NK cells plays a critical role in the pregnancy-induced remodeling of decidual arteries (Ashkar et al., 2000) . On the other hand, an abnormally high IFN-g milieu associated with an aberrant Th1/Th2 balance at the feto-maternal interface leads to adverse pregnancy outcomes, including pregnancy loss and pre-eclampsia (Chaouat et al., 2004) . Others have previously reported that IFN-g and TNF-a induce physiologic apoptotic cell death in villous cytotrophoblasts (Yui et al., 1994) . Aberrant regulation of these cytokines may therefore disturb normal placental function. This highlights the potential importance of a mechanism that tightly regulates local IFN-g levels at the feto-maternal interface. Too much or too little of this inflammatory cytokine may have severe consequences.
As demonstrated in our expression and co-culture studies, IFN-g-pretreated DSCs increase their cell surface expression of the antigen-presenting molecule, HLA-DR, and increase the production of cytokines by CD4 þ T cells. Since the decidua is at constant risk for ascending infection, our observed DSC response to IFN-g stimulation might be fundamental in the prevention of the spread of infection within the decidua. Further, IFN-g-stimulated DSCs concurrently increase their surface expression of PD-1 ligands as well as HLA-DR. In agreement with this observation, increased cytokine secretion from CD4 þ T cells upon the blockade of PD-1 ligands on DSCs was more remarkable in co-cultures with IFN-g-pretreated DSCs than with naïve DSCs. PD-1 ligand expression on DSCs may act as a negative feedback system to inhibit overproduction of potentially harmful cytokines, including IFN-g and TNF-a (Fig. 8) .
Maternal immune cells do and must recognize fetal antigens (Szekeres-Bartho, 2002) . Decidual immune cells are active during human pregnancy, although their phenotype and functional status may differ dramatically from their peripheral counterparts. In the periphery, PD-1 is not expressed on resting T cells but is induced rapidly after activation. In the decidua, PD-1 is highly expressed on T cells (Taglauer et al., 2008) suggesting that these cells are activated when compared with circulating maternal T cells. Interestingly, previous studies have reported the expression of PD-1 ligands on trophoblast cells and their differential expression across the gestational period (Petroff et al., 2002 (Petroff et al., , 2005 Holets et al., 2006) , supporting a significant role for PD-1 signaling in immune regulation at the feto-maternal interface. Our findings give DSCs an important, possibly central, immunoregulatory role in this environment. MHC class II expression on DSCs may aid in maternal T cell allorecognition of fetal antigen and drive decidual CD4 þ T cells toward an activated state. Concurrent B7-H1/B7-DC expression on DSCs allows for modulation of this activated state through PD-1 ligation and suppression of T helper cell inflammatory cytokine secretion. DSCs may provide a safety valve to avoid excessive T cell alloreactivity at the feto-maternal interface. Since term decidua was used as the cell source for DSCs in the present study, further functional assessment of DSCs from early gestational period is necessary to directly test this hypothesis. Finally, we appreciate the need for caution in the interpretation of our findings. We have investigated co-culture between DSCs and allogeneic CD4 þ T cells. Our investigations, while providing novel and important insights into the immune functionality of the DSC, do not address interactions between syngeneic T cells and DSCs. These latter investigations are underway.
In summary, we have demonstrated here that human DSCs constitutively express HLA-DR and PD-1 ligands and up-regulate the expression of these cell surface molecules upon stimulation with IFN-g and TNF-a. We have confirmed that PD-1 ligands on DSCs negatively modulate CD4 þ T cell cytokine production induced by TCR-MHC class II signaling. The communication between DSCs and decidual T cells via PD-1:PD ligands may be a critical mechanism for balancing local cytokine production. This, in turn, may be important in the regulation of an immunologic milieu that favors appropriate fetal growth, control of decidual pathogen exposures and continuation of pregnancy to term. 
CD4
þ T cells are activated upon TCR/CD3 binding with antigen presented by MHC class II molecule on DSCs. Decidual T cell cytokine production increases. Enhanced secretion of IFN-g and TNF-a from T cells leads to an up-regulation of B7-H1 and B7-DC on DSCs. T cell-expressed PD-1 binds to B7-H1/-DC and generates inhibitory co-stimulatory signals that negatively modulate cytokine productivity.
Functional PD-1 ligand expression on DSCs
